Back to Search
Start Over
Carboplatin Alone vs Carboplatin plus Epidoxorubicin as Second-Line Therapy for Cisplatin- or Carboplatin-Sensitive Ovarian Cancer
- Source :
- Gynecologic Oncology; April 2001, Vol. 81 Issue: 1 p3-9, 7p
- Publication Year :
- 2001
-
Abstract
- Objective.The aim of the study was to analyze the benefit/toxicity profile of a second-line treatment with carboplatin alone or carboplatin plus another non-cross-resistant drug (epidoxorubicin) in ovarian cancer patients sensitive to cisplatin-based chemotherapy at first-line treatment.
Details
- Language :
- English
- ISSN :
- 00908258 and 10956859
- Volume :
- 81
- Issue :
- 1
- Database :
- Supplemental Index
- Journal :
- Gynecologic Oncology
- Publication Type :
- Periodical
- Accession number :
- ejs847457
- Full Text :
- https://doi.org/10.1006/gyno.2001.6151